(19)
(11) EP 3 732 191 A2

(12)

(88) Date of publication A3:
08.08.2019

(43) Date of publication:
04.11.2020 Bulletin 2020/45

(21) Application number: 18896769.9

(22) Date of filing: 31.12.2018
(51) International Patent Classification (IPC): 
C07K 14/705(2006.01)
C12N 15/09(2006.01)
C07K 14/725(2006.01)
(86) International application number:
PCT/US2018/068134
(87) International publication number:
WO 2019/133969 (04.07.2019 Gazette 2019/27)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 29.12.2017 US 201762612031 P

(71) Applicant: Memorial Sloan-Kettering Cancer Center
New York, NY 10065 (US)

(72) Inventors:
  • SADELAIN, Michel
    New York, NY 10024 (US)
  • FEUCHT, Judith
    72813 St. Johann, Upfingen (DE)
  • HAMIEH, Mohamad
    New York, NY 10044 (US)
  • SUN, Jie
    New York, NY 10044 (US)
  • MANSILLA-SOTO, Jorge A.
    Forest Hills, NY 11375 (US)

(74) Representative: Zacco Denmark A/S 
Arne Jacobsens Allé 15
2300 Copenhagen S
2300 Copenhagen S (DK)

   


(54) ENHANCED CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF